Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy-Reference-Cited by-同舟云学术

Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy

Published:2015-07-08 Issue:7 Volume:10 Page:e0128910
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ahmed Muneeb,Kumar Gaurav,Navarro Gemma,Wang Yuanguo,Gourevitch Svetlana,Moussa Marwan H.,Rozenblum Nir,Levchenko Tatyana,Galun Eithan,Torchilin Vladimir P.,Goldberg S. Nahum

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference60 articles.

1. Delivery materials for siRNA therapeutics;R Kanasty;Nature materials,2013

2. A review of the current status of siRNA nanomedicines in the treatment of cancer;P Resnier;Biomaterials,2013

3. Therapeutic siRNA: principles, challenges, and strategies;K Gavrilov;The Yale journal of biology and medicine,2012

4. Immunotherapeutic strategies employing RNA interference technology for the control of cancers;CP Mao;Journal of biomedical science,2007

5. siRNA mediated the type 1 insulin-like growth factor receptor and epidermal growth factor receptor silencing induces chemosensitization of liver cancer cells;J Niu;Journal of cancer research and clinical oncology,2008

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibroblast growth factors induce hepatic tumorigenesis post radiofrequency ablation;Scientific Reports;2023-09-28

2. Repeated early-life exposure to anaesthesia and surgery causes subsequent anxiety-like behaviour and gut microbiota dysbiosis in juvenile rats;British Journal of Anaesthesia;2023-02

3. Immune modulation by molecularly targeted photothermal ablation in a mouse model of advanced hepatocellular carcinoma and cirrhosis;Scientific Reports;2022-08-24

4. Myofibroblasts: A key promoter of tumorigenesis following radiofrequency tumor ablation;PLOS ONE;2022-07-20

5. Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment;Bioscience Reports;2022-07